Immunity免疫

Immunity(英文缩写 IMMUNITY),ISSN 1074-7613,eISSN 1097-4180,中文译名:免疫 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
30.600
JCR 分区
Q1
CAS 分区
B1
近一年发文量
254
本站 PubMed 收录统计

发文量统计区间:2025-11-01 至 2026-10-31,按本站收录文献的发表日期统计。

ISSN: 1074-7613 · eISSN: 1097-4180 · 缩写: IMMUNITY ·中文: 免疫

期刊介绍

选择期刊介绍栏目

期刊简介

Immunity 是免疫学领域最具影响力的原创研究期刊之一,发表涵盖先天免疫、适应性免疫、炎症、免疫耐受与自身免疫等方向的突破性成果。其读者群主要是免疫学及相关领域的科研人员、临床研究者与研究生,内容强调机制性发现与实验证据的严谨性,常成为免疫学前沿方向的重要发表平台。

研究方向

主要方向包括免疫细胞发育与活化、信号转导、宿主与病原体互作、黏膜免疫、肿瘤免疫、免疫代谢及免疫相关疾病机制。论文类型以原创研究长文为主,兼有综述、观点与短篇报道,强调从分子到整体水平的机制解析。

期刊特色

研究取向偏重概念创新与机制深度,要求实验体系完整、数据扎实并能推动领域认知。论文通常篇幅较长、图表丰富,适合有系统性工作积累的免疫学实验室投稿,也适合关注免疫学重大进展的跨学科读者阅读。

投稿难度

投稿难度很高,竞争激烈,对新颖性、机制深度和数据完整性要求严格。建议在投稿前充分评估工作的概念突破点,补充关键体内验证与独立重复,并准备好应对多轮审稿意见;仅凭分区或影响因子判断录用可能性并不可靠。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
202143.474Q1
202232.400Q1
202325.500Q1
202426.300Q1
202530.600Q1

Immunity 最新收录文献

  1. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    1. Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy.

    1. 在癌症免疫治疗中,远处淋巴结可代偿被切除的肿瘤引流淋巴结
    作者:
    Lutz Menzel, Hengbo Zhou, James W Baish, Meghan J O'Melia, Laurel B Darragh, Derek N Effiom, Emma Specht, Juliane Czapla, Pin-Ji Lei, Johanna J Rajotte, Lingshan Liu, Mohammad R Nikmaneshi, Mohammad S Razavi, Matthew G Vander Heiden, Jessalyn M Ubellacker, Lance L Munn, Sana D Karam, Genevieve M Boland, Sonia Cohen, Timothy P Padera
    日期:
    2026-10-01

    Surgical removal of tumor-draining lymph nodes (tdLNs) is commonly performed in cancer patients. Here, we investigated whether immune checkpoint blockade (ICB) responses persist after resection of tdLNs, important sites for the initiation and maintenance of anti-cancer immunity. Melanoma patients remained responsive to programmed death 1 (PD-1) blockade after regional LN dissection. Similarly, ICB efficacy persisted after tdLN resection in orthotopic murine melanoma and mammary carcinoma models. Following tdLN removal, interstitial fluid containing soluble antigen was diverted through interstitial spaces across lymphosome boundaries to distant LNs, wherein cancer-derived antigen was acquired and presented to T cells by LN-resident type I conventional dendritic cells. These responses persisted after primary tumor resection and supported ICB-induced systemic immunity. Locoregional delivery of ICB to compensatory LNs enhanced anti-cancer responses after tdLN resection. Consistently, ICB responses in head and neck cancer patients were associated with reactive LNs at distant sites. Thus, antigen rerouting enables distant LNs to compensate for resected tdLNs and sustain anti-cancer immunity, including responses enhanced by immunotherapy.

  2. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    2. Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction.

    2. 大规模TCR-pMHC配对的功能评估可实现计算机模拟TCR反应性预测
    作者:
    Marius Messemaker, Bjørn P Y Kwee, Živa Moravec, Sam de Paauw, Jos Urbanus, Daniel Álvarez-Salmoral, Jeroen Geerligs, Ren Xie, Rhianne Voogd, Ben Morris, Aurélie Guislain, Yaël Winkler, Connor A Richterich, Maike Mussmann, Marijn Bakker, Maxime Steinmetz, Matyas Iras, Eric Marcus, Jonas Teuwen, Anastassis Perrakis, Roderick L Beijersbergen, Wouter Scheper, Ton N Schumacher
    日期:
    2026-10-01

    Accurate prediction of T cell receptor (TCR) reactivity is a long-standing goal in immunology. Here, we asked whether functional validation of TCR-peptide-major histocompatibility complex (MHC) (TCR-pMHC) pairs at scale alters performance estimates of TCR-pMHC reactivity prediction models. We developed a TCR rapid assembly platform (T-RAP) that allowed the generation of large and uniform TCR libraries. T-RAP enabled evaluation of TCR signaling or MHC multimer binding of thousands of previously reported TCR-pMHC pairs under standardized conditions. In this setting of systematic standardized evaluation, only ∼50% of these TCRs showed the previously reported TCR reactivity. Notably, AlphaFold3 structural predictions showed good performance in identifying reactive TCR-pMHC pairs within the set of TCRs that experimentally validated without any task-specific training. AlphaFold3 structural predictions could likewise be used to shortlist TCRs reactive to patient-specific cancer neoantigens. In silico prediction of TCR-pMHC reactivity thus has greater feasibility than previously assumed, with implications for basic research and clinical application.

  3. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    3. Glucose-deprived tumor microenvironment activates AMP-activated protein kinase to drive adoptively transferred T helper 9 cell senescence.

    3. 葡萄糖缺乏的肿瘤微环境激活AMP活化蛋白激酶,驱动过继转移的辅助性T细胞9衰老
    作者:
    Jiemeng Fu, Siyu Pei, Jiadan Du, Xiuyu Deng, Xindong Wang, Tong Li, Huan Huang, Jialin Ye, Jing Xu, Xueqing Wang, Youwei He, Yu Li, Yitong Sun, Yuan Wang, Ji-Hong Yang, Jing-Hua Li, Dongfang Dai, Yichuan Xiao
    日期:
    2026-10-01

    T helper 9 (Th9) cells show promise for adoptive cell therapy (ACT) against solid tumors. However, clinical application faces challenges regarding their persistence in the tumor microenvironment (TME). We observed that tumor growth gradually reduced glucose concentrations in the TME, accompanied by a decline in transferred Th9 cells and their effector functions, due to Th9 cell senescence. Restoring glucose concentrations suppressed Th9 cell senescence, thereby improving their persistence. Mechanistically, glucose-deprivation-activated AMP-activated protein kinase (AMPK), triggering downstream leucine-zipper and sterile-α motif kinase (ZAK)-nuclear factor κB (NF-κB)-inducing kinase (NIK) cascades that suppressed noncanonical NF-κB signaling and interleukin (IL)-9 production, ultimately driving Th9 cell senescence. ZAK-associated chimeric antigen receptor (CAR)-T cell senescence was linked to compromised therapeutic efficacy in human cancers. Targeting ZAK rejuvenated Th9 cells and enhanced CAR-Th9 cell efficacy against solid tumors. Our study uncovers a mechanism by which nutrient deprivation promotes Th9 cell senescence to compromise persistence, highlights the potential of targeting ZAK to rejuvenate CAR-Th9 cells for solid tumor therapy.

  4. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    4. Microglia with distinct origins and non-canonical phenotypes coexist within the border-like niche of the brain's circumventricular organs.

    4. 具有不同起源和非经典表型的小胶质细胞共存于大脑室周器官的边界样微环境中
    作者:
    Hannah Van Hove, Jonathan Bastos, Daliya Kancheva, Mónica Vara-Pérez, Marie-France Dorion, Frederike Westermann, Can Ulutekin, Hadis Shakeri, Leen Ali, Ayla Line Lievens, Maud Mayoux, Nele Sterczyk, Francesca Biscu, Laura Meysman, Isabelle Scheyltjens, Karen De Vlaminck, Ana Rita Pombo Antunes, Wiebke Mildenberger, Lukas Amann, Diego Gomez-Nicola, Ilse Smolders, Sonia Tugues, Florent Ginhoux, Marco Prinz, Charlotte L Scott, Burkhard Becher, Jo A Van Ginderachter, Melanie Greter, Kiavash Movahedi
    日期:
    2026-09-29

    Circumventricular organs (CVOs) are small brain regions lacking a blood-brain barrier, giving neurons direct access to blood-borne signals, yet how these microenvironments shape the origin and phenotype of local macrophages remains unclear. Using multi-omics, we characterized the immune landscape of two CVOs, the area postrema (AP) and median eminence (ME), revealing brain-border-like environments with a unique macrophage compartment. CVO microglia showed a distinct, heterogeneous phenotype, including a CLEC7A myelin-associated subset in the ME, shaped by ageing and metabolism. CVO microglia were ontogenically diverse: fetal monocytes entered the CVOs perinatally and generated long-lived monocyte-derived microglia that fully adopted a yolk-sac-derived microglia identity. After depletion, CVO microglia were repopulated by local Sall1 cells but also by monocytes in the AP. Similarly, perivascular CVO border-associated macrophages displayed a distinct phenotype and origin. Our findings establish CVOs as specialized immune niches that shape local macrophages, reflecting the immune and metabolic demands of these environments.

  5. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    5. Targeting a site of vulnerability on circumsporozoite protein inhibits Plasmodium vivax malaria infection.

    作者:
    Ganesh R R Visweswaran, Pooya Mahdavi, Kamalakannan Vijayan, Francis B Ntumngia, Bart L Staker, Samantha J Barnes, Pradeep A Subramani, Andrew Raappana, Nicholas Dambrauskas, Elizabeth K K Glennon, Surendra K Kolli, Madison M Ogbondah, Alexander Watson, Nelly Camargo, Banumathi Sankaran, Pongsakorn Thawornpan, Rachaneeporn Jenwithisuk, Peter J Myler, Stefan H I Kappe, Wanlapa Roobsoong, Patchanee Chootong, Jetsumon Sattabongkot, Alexis Kaushansky, Vladimir Vigdorovich, John H Adams, D Noah Sather
    日期:
    2026-09-24

    Circumsporozoite protein (CSP) is the most abundant Plasmodium sporozoite surface antigen. It is the major component of licensed Plasmodium falciparum vaccines and, hence, is the logical lead candidate for Plasmodium vivax (P. vivax) vaccines. However, our limited knowledge of protective B cell epitopes on P. vivax CSP remains a major roadblock. Here we identified two Plasmodium vivax CSP (PvCSP) B cell epitopes, PvCSP-A and PvCSP-B/NAGG, by screening inhibitory plasma from P. vivax-infected individuals. The epitopes were located in the N- and C-terminal regions of PvCSP, respectively, and were distinct from the canonical central repeat region epitope. We isolated a monoclonal antibody, GRAM-4, that recognized the PvCSP-B/NAGG epitope and mediated potent inhibition of traversal, hepatocyte invasion, and liver-stage development in vitro, confirming PvCSP-B/NAGG as a genuine neutralization target. Structural resolution of the GRAM-4:PvCSP-B/NAGG interaction at 2.65 Å revealed the molecular basis of epitope recognition, providing a blueprint for PvCSP vaccine development.

  6. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    6. Germinal center interleukin-4 microniches drive tissue divergence of IgE memory B cell responses.

    6. 生发中心白细胞介素-4微环境驱动IgE记忆B细胞反应的组织分化
    作者:
    Sergio Villazala-Merino, Lucas Bertoia, Romain Fenouil, Mohammed Zghaebi, Myriam Moussa, Samuel Origlio, Claude Gregoire, Laura Almada, Mara Esposito, Stefano A P Colombo, Adriana Gruppi, Judith E Allen, Andrew S MacDonald, Nicolas Fazilleau, Pierre Bruhns, Julia Eckl-Dorna, Carolyn G King, Mauro Gaya
    日期:
    2026-09-23

    Immunoglobulin E (IgE) drives allergy, yet how memory B cells (MBCs) reactivate to produce IgE, and how tissue localization shapes recall responses, remains unclear. Using mouse models of airborne exposure to house dust mites and Alternaria, we found that allergen sensitization generated lymph node (LN)- and lung-resident MBCs. Upon allergen re-exposure, MBCs follow two differentiation trajectories: a germinal center (GC)-dependent pathway, generating IgG1 and IgE plasma cells (PCs) and occurring predominantly in LNs, and a GC-independent pathway, generating mainly IgG1 PCs and present in both organs. GC re-entry granted MBCs access to an interleukin (IL)-4-rich microniche formed by T follicular helper (Tfh) cells, which was essential for IgE production. Disrupting GC re-entry, IL-4 signaling, or Tfh cell-derived IL-4 during recall markedly reduced allergen-specific IgE. These findings reveal a spatially and cytokine-restricted mechanism that confines IgE memory to lymphoid organs, positioning GC IL-4 microniches as anatomical safeguards against IgE production at barrier sites frequently exposed to environmental antigens.

  7. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    7. Sensory neuronal mTORC1 kinase signaling establishes neuroimmune memory that initiates allergic immunity.

    7. 感觉神经元mTORC1激酶信号建立神经免疫记忆,从而启动过敏性免疫
    作者:
    Xueping Zhu, Haibo Yang, Haoting Zhan, Isabela J Kernin, Dean R Buttaci, Ngoc Le, Cai Han, Parth R Naik, Peri R Matatia, Sarah Zaghouani, Lillian R Delacruz, Lukas M Altenburger, Neal P Smith, Elena Wu, Rebecca Londoner, Cameron H Flayer, Zhengwang Sun, Alison E Ringel, Alexandra-Chloe Villani, Rod A Rahimi, Caroline L Sokol
    日期:
    2026-09-22

    Environmental allergens are enriched in protease activity, which activates cutaneous sensory neurons, triggering itch and substance P release to promote migration of T helper (Th)2 cell-skewing CD301b dendritic cells and initiate allergic immunity. However, allergens are typically encountered through repeated subthreshold exposures, and how these cumulatively induce sensitization is unknown. We identified a sensory neuron-intrinsic mechanism of neuroimmune memory. Protease allergen exposure induced sustained mechanistic target of rapamycin complex 1 (mTORC1) kinase signaling and transcriptional activator peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α)-associated mitochondrial remodeling in sensory neurons, establishing a metabolically primed state with enhanced neuronal responsiveness. Upon allergen re-exposure, this state drove enhanced itch, CD301b dendritic cell migration, and Th2 cell differentiation. Disrupting neuronal mTORC1 signaling or mitochondrial stability abrogated this amplification while sparing primary responses. This mechanism generalized across distinct protease allergens, revealing mTORC1-driven metabolic reprogramming in sensory neurons as a form of innate neuroimmune memory underlying allergen cross-sensitization and polysensitization.

  8. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    8. Cancers modulate processing and presentation of p53 neoantigens to evade T cell detection.

    8. 癌症通过调节p53新抗原的加工和呈递,逃避T细胞的检测
    作者:
    Koji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, Caroline G Fahey, Kemin Tan, Robert J Mallis, Alexander Gusev, Kenneth L Kehl, Jia Luo, Allyson Karmazyn, Elizabeth L Holliday, Daniel J Masi, Katarzyna J Zienkiewicz, Connor J Hennessey, Rafael B Blasco, Tran C Thai, Grace M Gibbons, Sophie Kivlehan, Patrick Lizotte, Cloud P Paweletz, Andrew J Aguirre, Keith L Ligon, Roberto Chiarle, Matthew J Lang, David A Barbie, Ellis L Reinherz
    日期:
    2026-09-17

    TP53 mutations occur early in malignant transformation as truncal events in tumor evolution and are therefore generally present in all descendant tumor cells, creating an immunological vulnerability. Here, we examined the immunogenicity and antigenicity of p53 neoantigens emerging from these truncal mutations. Comprehensive immunopeptidomics revealed that hotspot mutations in human tumors preferentially localize to p53 regions resistant to antigen processing, thereby avoiding display altogether. Moreover, for neoantigens presentable by HLA-A02:01 or HLA-B07:02 and structurally divergent from corresponding wild-type p53 peptide-HLA complexes, clinical tumors commonly lacked the relevant presenting HLA allele. Tumor cells further resisted T cell killing through increased activity of the aminopeptidase ERAP1, preventing display of high-affinity HLA-A02:01 complexes containing an immunogenic p53-derived 11-mer, or by expressing low-affinity HLA-A02:01 complexes containing a p53-derived 9-mer with poor antigenicity despite high-quality human TCRs. These findings define mechanisms by which tumors restrict targetable truncal neoantigen display and suggest immunopeptidome shift strategies to circumvent immune escape.

  9. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    9. Effector differentiation by stem-like intraepithelial γδ T cells is required for host defense against infection.

    9. 干细胞样上皮内γδ T细胞介导的效应分化是宿主抵御感染所必需的
    作者:
    Shiyuan Xie, Qi Xing, Qian Zhang, Hao Zhang, Qinli Sun, Qiuyan Lan, Zhiyu Gu, Birui Pan, Peng Wei, Yujie Fu, Xiaohu Wang, Chen Dong
    日期:
    2026-09-09

    该文献暂无摘要。

  10. JCR分区: Q1 CAS分区: B1 影响因子: 30.6

    10. A pulmonary innate lymphoid cell-driven serotonergic neuroimmune axis orchestrates airway hyperreactivity and cough hypersensitivity.

    10. 肺固有淋巴细胞驱动的5-羟色胺能神经免疫轴协调气道高反应性和咳嗽超敏反应
    作者:
    Chia-Hui Luo, Jheng-Syuan Shao, Alan Chuan-Ying Lai, Wei-Chang Huang, Ko-Chien Wu, Wei-Yu Chen, Chih-Cheng Chen, Nicholas W Lukacs, Ya-Jen Chang
    日期:
    2026-09-07

    Asthma is a heterogeneous disease characterized by airway hyperreactivity (AHR) and chronic cough, exacerbated by respiratory viruses or allergen exposure. Yet, the immune pathway-mediated serotonergic circuits underlying these responses remain poorly defined. Here, we identified a serotonergic neuroimmune axis in which pulmonary group 2 innate lymphoid cells (ILC2s) expressed tryptophan hydroxylase-1 (Tph1) and released serotonin via CCAAT/enhancer-binding protein beta (C/EBPβ)-dependent transcription following interleukin (IL)-33 stimulation. Tph1 deficiency in ILC2s and adoptive transfer experiments demonstrated that ILC2-derived serotonin amplified type 2 cytokine production via 5-hydroxytryptamine (5-HT)-NF-κB activation, resulting in exacerbated AHR in respiratory syncytial virus-driven asthmatic models. Using engineered viral tools, we showed that ILC2-derived serotonin sensitized vagal sensory neurons through 5-HT to promote cough hypersensitivity. Clinically, asthma patients exhibited elevated TPH1 and plasma serotonin levels, both of which correlated with type 2 cytokines. Together, these findings reveal that an ILC2-driven serotonergic circuit contributes to asthma pathophysiology and highlight serotonergic signaling as a therapeutic target.

在 Immunity 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊